title: N-acetylcysteine improves cytotoxic activity of cirrhotic rat liver-associated mononuclear cells.
abstract: Liver cirrhosis, which is associated with decreased plasma and hepatic glutathione (GSH), has been reported to cause the suppression of NK activity in peripheral blood mononuclear cells. Since low GSH levels in lymphocytes are known to alter lymphocyte function, we examined the correlation between intracellular GSH levels and the cytotoxic activity of liver-associated mononuclear cells (liver MNC). We show here that rat liver contains a highly active population of NK cells (CD3- NKR-P1 + cells) that kill Yac-1 in vitro and that the cytotoxic activity of this NK population is directly proportional to liver MNC GSH. This proportionality is independent of the methods used to alter GSH level. Thus, in vitro treatment of liver MNC with buthionine sulfoximine to lower GSH levels lowers the cytotoxic activity. MNC from cirrhotic liver, in which implanted tumor cells grow faster, have both low GSH levels and low cytotoxicity, and supplementation of cirrhotic liver MNC with N-acetylcysteine raises GSH levels and increases cytotoxicity. These findings suggest a physiologic mechanism, i.e. decreased GSH, may be causally associated with the increased incidence of hepatoma in cirrhotic individuals and the increased growth of hepatoma cells in cirrhotic animals. Thus, we suggest that the GSH is important to the optimal functioning of the hepatic immunity that protects against hepatoma development.
authors.affiliation: Department of Gastroenterological Surgery, Graduate School of Medicine, Kyoto, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Tsuyuki
authors.forename: A
authors.initials: A
authors.lastname: Yamauchi
authors.forename: H
authors.initials: H
authors.lastname: Nakamura
authors.forename: Y
authors.initials: Y
authors.lastname: Nakamura
authors.forename: K
authors.initials: K
authors.lastname: Kinoshita
authors.forename: T
authors.initials: T
authors.lastname: Gomi
authors.forename: Y
authors.initials: Y
authors.lastname: Kawai
authors.forename: T
authors.initials: T
authors.lastname: Hirose
authors.forename: K
authors.initials: K
authors.lastname: Furuke
authors.forename: I
authors.initials: I
authors.lastname: Ikai
authors.forename: K
authors.initials: K
authors.lastname: Ohmori
authors.forename: Y
authors.initials: Y
authors.lastname: Yamaoka
authors.forename: T
authors.initials: T
authors.lastname: Inamoto
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology*; D000818:Animals; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D002455:Cell Division; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005978:Glutathione / Q000096:biosynthesis; D007694:Killer Cells, Natural / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000166:cytology*; D008106:Liver Cirrhosis, Experimental / Q000276:immunology / Q000473:pathology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013853:Thioacetamide; D014407:Tumor Cells, Cultured / Q000166:cytology
chemical_list: D013853:Thioacetamide; D019328:Buthionine Sulfoximine; D005978:Glutathione; D000111:Acetylcysteine